Literature DB >> 6128586

Nifedipine in the treatment of diffuse oesophageal spasm.

S M Nasrallah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6128586     DOI： 10.1016/s0140-6736(82)90145-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm.

Authors:  T P Short; E Thomas
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 2.  Current concepts on pathophysiology, diagnosis and treatment of diffuse oesophageal spasm.

Authors:  M Storr; H D Allescher; M Classen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Primary oesophageal motility disorders. Current therapeutic concepts.

Authors:  M Traube; R W McCallum
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

4.  [Chronic motility disorders of the upper gastrointestinal tract in the elderly. Pharmaceutical, endoscopic and operative therapy].

Authors:  J-U Sonne; J F Erckenbrecht
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

Review 5.  Rational pharmacotherapy of gastrointestinal motility disorders.

Authors:  P Demol; H J Ruoff; T R Weihrauch
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

Review 6.  Medical treatment of esophageal motility disorders.

Authors:  H D Allescher; W J Ravich
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.